Clinical Trial Update: Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 1]

View source ↗

Summary

This report documents the completion of a Phase 1 trial evaluating the effect of darapladib on cantharidin-induced inflammatory blisters in adults with type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Darapladib (darapladib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED